Blood of Recovered COVID-19 Patients Shows Little Benefit as Treatment, Study Finds
Indian study shows convalescent plasma' failed to reduce death ratesActualités similaires
Articles similaires à Blood of Recovered COVID-19 Patients Shows Little Benefit as Treatment, Study Finds
Pfizer-BioNTech Vaccine Neutralizes Brazil Variant of COVID-19, Study Finds
Researchers find vaccine roughly as effective against Brazilian variant as it was against other, less contagious versions of virusActualités similaires
In Italy, the Council of State says YES to hydroxychloroquine as a treatment for Covid-19
Through order 7097/2020 issued today, the Italian Council of State says yes to the use of hydroxychloroquine as a treatment for Covid-19, provided it is ...Blood of Recovered COVID-19 Patients Shows Little Benefit as Treatment, Study Finds
Indian study shows convalescent plasma' failed to reduce death ratesActualités similaires
US Grants Emergency Use Authorization for Blood Plasma as COVID-19 Treatment
Some experts, including those inside the US government, contended that granting the authorization is prematureActualités similaires
Drug Touted by Trump as COVID-19 Treatment Tied to Increased Death Risk, Study Finds
Demand for hydroxychloroquine, a drug approved decades ago, surged after Trump touted its use as a coronavirus treatment in early AprilActualités similaires
Chinese Scientists Test Treatment Using Antibodies from Recovered COVID-19 Patients
US scientists say the Chinese treatment 'has potential,' but it may take a long time before determining if it's a realistic optionActualités similaires
University of Oxford Study Set to Test Hydroxychloroquine as COVID-19 Treatment
Over 40,000 health care workers worldwide will explore the drug's limitsActualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
